Abstract
For the past half-century, the lumboperitoneal shunt (LP shunt) has been the leading surgical treatment for idiopathic intracranial hypertension (IIH). More recently in Japan, this procedure has been offered in the management of Normal Pressure Hydrocephalus (NPH). In some institutions, the LP shunt comprises up to 40 % of all cerebrospinal fluid (CSF) shunting. One of the reasons that LP shunt is used when treating patients with IIH is because it is difficult to place a ventricular catheter in ventricles that are usually small, in this condition. Furthermore, the avoidance of an intracranial procedure with LP shunt spares the small risk of intracranial hemorrhage while passing a catheter through the brain parenchyma. It is to be remembered, however, that given the pathogenetic mechanism of IIH, LP shunt and optic nerve fenestration (ONF) are symptomatic treatment while reducing patients weight (diet, bariatric surgery, etc.) and/or dural sinus stenting intervene on the cause itself of IIH and therefore should be offered first.
| Original language | English (US) |
|---|---|
| Title of host publication | Complications of CSF Shunting in Hydrocephalus: Prevention, Identification, and Management |
| Publisher | Springer International Publishing |
| Pages | 203-211 |
| Number of pages | 9 |
| ISBN (Print) | 9783319099613, 9783319099606 |
| DOIs | |
| State | Published - Jan 1 2015 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Complications specific to lumboperitoneal shunt. / Jusué-Torres, Ignacio; Hoffberger, Jamie B.; Rigamonti, Daniele.
Complications of CSF Shunting in Hydrocephalus: Prevention, Identification, and Management. Springer International Publishing, 2015. p. 203-211.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Complications specific to lumboperitoneal shunt
AU - Jusué-Torres, Ignacio
AU - Hoffberger, Jamie B.
AU - Rigamonti, Daniele
PY - 2015/1/1
Y1 - 2015/1/1
N2 - For the past half-century, the lumboperitoneal shunt (LP shunt) has been the leading surgical treatment for idiopathic intracranial hypertension (IIH). More recently in Japan, this procedure has been offered in the management of Normal Pressure Hydrocephalus (NPH). In some institutions, the LP shunt comprises up to 40 % of all cerebrospinal fluid (CSF) shunting. One of the reasons that LP shunt is used when treating patients with IIH is because it is difficult to place a ventricular catheter in ventricles that are usually small, in this condition. Furthermore, the avoidance of an intracranial procedure with LP shunt spares the small risk of intracranial hemorrhage while passing a catheter through the brain parenchyma. It is to be remembered, however, that given the pathogenetic mechanism of IIH, LP shunt and optic nerve fenestration (ONF) are symptomatic treatment while reducing patients weight (diet, bariatric surgery, etc.) and/or dural sinus stenting intervene on the cause itself of IIH and therefore should be offered first.
AB - For the past half-century, the lumboperitoneal shunt (LP shunt) has been the leading surgical treatment for idiopathic intracranial hypertension (IIH). More recently in Japan, this procedure has been offered in the management of Normal Pressure Hydrocephalus (NPH). In some institutions, the LP shunt comprises up to 40 % of all cerebrospinal fluid (CSF) shunting. One of the reasons that LP shunt is used when treating patients with IIH is because it is difficult to place a ventricular catheter in ventricles that are usually small, in this condition. Furthermore, the avoidance of an intracranial procedure with LP shunt spares the small risk of intracranial hemorrhage while passing a catheter through the brain parenchyma. It is to be remembered, however, that given the pathogenetic mechanism of IIH, LP shunt and optic nerve fenestration (ONF) are symptomatic treatment while reducing patients weight (diet, bariatric surgery, etc.) and/or dural sinus stenting intervene on the cause itself of IIH and therefore should be offered first.
UR - http://www.scopus.com/inward/record.url?scp=84944526103&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84944526103&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-09961-3_14
DO - 10.1007/978-3-319-09961-3_14
M3 - Chapter
AN - SCOPUS:84944526103
SN - 9783319099613
SN - 9783319099606
SP - 203
EP - 211
BT - Complications of CSF Shunting in Hydrocephalus: Prevention, Identification, and Management
PB - Springer International Publishing
ER -